BioSpace News Archive

PORTLAND, Maine, Feb. 13, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, will report unaudited financial results for the year ended December 31, 2019 after the market closes on Tuesday, February 18, 2020. The Company has scheduled a conference call on Wednesday,

Following comprehensive review of the available evidence, the Expert Advisory Group on Medical Assistance in Dying released a report cautioning that evolving assisted dying policies must not put the lives of Canadians who live with mental illness at risk.

NORTH MIAMI, Fla. , Feb. 13, 2020 /PRNewswire/ -- Carevive Systems, a leading oncology-focused health technology company, announced today that it has received Series C funding from new investors Philips Health Technology Ventures and Debiopharm Innovation Fund, and existing investors Cerner Capital, HLM Venture Partners, LRVHealth, and Co-Founder/CEO Madelyn Trupkin Herzfeld

Feb. 13, 2020 14:30 UTC New molecular analyses to be presented at ASCO Genitourinary Cancers Symposium DURHAM, N.C.--( BUSINESS WIRE )-- GeneCentric Therapeutics today announced it will present two posters during the ASCO GU Cancers Symposium to be held in San Francisco, California, February 13-15, 2020. The data are derived from GeneCentric’s expertise in the identification of RNA-based Predictive Response Signatures and through collaborations with researchers at leading i

S4 Medical oversubscribes round in preparation for clinical studies

Feb. 13, 2020 15:00 UTC BEIJING--( BUSINESS WIRE )-- Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that the National Medical Products Administration (NMPA) has approved its 8-gene Lung Cancer Assay and high-throughput NGS platform GENETRON S2000 to empower comprehensive panel genomic testing for more patients. The 8-gene Lung Cancer Assay is the first lung cancer clinical testing assay bas

Agreement secures a 2D patented printing technology that will significantly boost production capacity and reduce production costs Further protects CAUMZ™ and HCC011 with four additional manufacturing patents OTTAWA, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Tetra Bio Pharma Inc. (“ Tetra ” or the “ Company ”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced it has signed a definitive manufacturing agreement with Vitiprints LLC, for the

Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, announces the launch of ReadyMap services, an expansion of its Shotgun Mutagenesis Epitope Mapping platform for rapid mapping of antibody binding sites on pre-validated protein targets.

VAC Unveils Initial Agenda for More Effective Treatment of Active Service Members & Veterans with Brain Trauma

Canadian health science companies define a new generation of innovation on the world stage